Literature DB >> 25223504

Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone.

Tore Bjerregaard Stage1, Rasmus Steen Pedersen, Per Damkier, Mette Marie Hougaard Christensen, Søren Feddersen, John Teilmann Larsen, Kurt Højlund, Kim Brøsen.   

Abstract

AIMS: Our objective was to investigate the steady-state pharmacokinetic and pharmacodynamic interaction between the antidepressive herbal medicine St John's wort and the antidiabetic drug metformin.
METHODS: We performed an open cross-over study in 20 healthy male subjects, who received 1 g of metformin twice daily for 1 week with and without 21 days of preceding and concomitant treatment with St John's wort. The pharmacokinetics of metformin was determined, and a 2 h oral glucose tolerance test was performed.
RESULTS: St John's wort decreased the renal clearance of metformin but did not affect any other metformin pharmacokinetic parameter. The addition of St John's wort decreased the area under the glucose concentration-time curve [702 (95% confidence interval, 643-761) vs. 629 min*mmol/L (95% confidence interval, 568-690), P = 0.003], and this effect was caused by a statistically significant increase in the acute insulin response.
CONCLUSIONS: St John's wort improves glucose tolerance by enhancing insulin secretion independently of insulin sensitivity in healthy male subjects taking metformin.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  St John's wort; drug-herb interaction; metformin; pharmacodynamics; pharmacokinetics

Mesh:

Substances:

Year:  2015        PMID: 25223504      PMCID: PMC4309635          DOI: 10.1111/bcp.12510

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  39 in total

1.  Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.

Authors:  Steffen Bauer; Elke Störmer; Andreas Johne; Hagen Krüger; Klemens Budde; Hans-Hellmut Neumayer; Ivar Roots; Ingrid Mai
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

Review 2.  Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics.

Authors:  Stephen H Wright
Journal:  Toxicol Appl Pharmacol       Date:  2005-05-01       Impact factor: 4.219

3.  Pharmacokinetics of metformin after intravenous and oral administration to man.

Authors:  P J Pentikäinen; P J Neuvonen; A Penttilä
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

Review 4.  Pharmacokinetic interactions of drugs with St John's wort.

Authors:  Shufeng Zhou; Eli Chan; Shen-Quan Pan; Min Huang; Edmund J D Lee
Journal:  J Psychopharmacol       Date:  2004-06       Impact factor: 4.153

5.  Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.

Authors:  Silke C Mueller; Bernhard Uehleke; Heike Woehling; Michael Petzsch; Jolanta Majcher-Peszynska; Eva-Maria Hehl; Hartwig Sievers; Bruno Frank; Anne-Kathrin Riethling; Bernd Drewelow
Journal:  Clin Pharmacol Ther       Date:  2004-06       Impact factor: 6.875

6.  Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

Authors:  L S Hermann; B Scherstén; P O Bitzén; T Kjellström; F Lindgärde; A Melander
Journal:  Diabetes Care       Date:  1994-10       Impact factor: 19.112

7.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.

Authors:  Christer Tannergren; Helena Engman; Lars Knutson; Mikael Hedeland; Ulf Bondesson; Hans Lennernäs
Journal:  Clin Pharmacol Ther       Date:  2004-04       Impact factor: 6.875

9.  Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis.

Authors:  M J Knol; J W R Twisk; A T F Beekman; R J Heine; F J Snoek; F Pouwer
Journal:  Diabetologia       Date:  2006-03-07       Impact factor: 10.122

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  9 in total

1.  Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers.

Authors:  Mette Marie Hougaard Christensen; Kurt Højlund; Ole Hother-Nielsen; Tore Bjerregaard Stage; Per Damkier; Henning Beck-Nielsen; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2015-05-05       Impact factor: 2.953

Review 2.  The clinical significance and costs of herbs and food supplements used by complementary and alternative medicine for the treatment of cardiovascular diseases and hypertension.

Authors:  S G Chrysant
Journal:  J Hum Hypertens       Date:  2015-05-21       Impact factor: 3.012

3.  Limited sampling strategy for determining metformin area under the plasma concentration-time curve.

Authors:  Ana Beatriz Santoro; Tore Bjerregaard Stage; Claudio José Struchiner; Mette Marie Hougaard Christensen; Kim Brosen; Guilherme Suarez-Kurtz
Journal:  Br J Clin Pharmacol       Date:  2016-07-24       Impact factor: 4.335

Review 4.  A Comprehensive Review of Drug-Drug Interactions with Metformin.

Authors:  Tore Bjerregaard Stage; Kim Brøsen; Mette Marie Hougaard Christensen
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447

5.  Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteers.

Authors:  Elise J Smolders; Angela Colbers; Clara T M M de Kanter; Kirsten Velthoven-Graafland; Leonie T Wolberink; Noor van Ewijk-Beneken Kolmer; Joost P H Drenth; Rob E Aarnoutse; Cees J Tack; David M Burger
Journal:  Br J Clin Pharmacol       Date:  2017-06-06       Impact factor: 4.335

Review 6.  St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

Authors:  Gita Kholghi; Shirin Arjmandi-Rad; Mohammad-Reza Zarrindast; Salar Vaseghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-16       Impact factor: 3.000

Review 7.  HDI Highlighter, The First Intelligent Tool to Screen the Literature on Herb-Drug Interactions.

Authors:  Anthony Cnudde; Patrick Watrin; Florence Souard
Journal:  Clin Pharmacokinet       Date:  2022-05-31       Impact factor: 5.577

Review 8.  Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications.

Authors:  Ramesh C Gupta; Dennis Chang; Srinivas Nammi; Alan Bensoussan; Kellie Bilinski; Basil D Roufogalis
Journal:  Diabetol Metab Syndr       Date:  2017-07-26       Impact factor: 3.320

Review 9.  Hypericum perforatum: Traditional uses, clinical trials, and drug interactions.

Authors:  Seyedeh Zahra Nobakht; Maryam Akaberi; Amir Hooshang Mohammadpour; Ali Tafazoli Moghadam; Seyed Ahmad Emami
Journal:  Iran J Basic Med Sci       Date:  2022-09       Impact factor: 2.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.